HomeNewsBusinessDelhi-Mumbai back as busiest air route, sees highest growth in September
Trending Topics

Delhi-Mumbai back as busiest air route, sees highest growth in September

Since domestic flights resumed in May after the coronavirus-imposed lockdown, non-metro routes have been the busiest.

September 22, 2020 / 11:56 IST
Story continues below Advertisement

In one more indication that air traffic is slowly but surely trending towards pre-COVID-19 levels, the Delhi-Mumbai route is now growing the fastest.

For some online travel agencies, Delhi-Mumbai is now the busiest route of all, also signalling an uptick in corporate travel.

Story continues below Advertisement

The route, with nearly 50,000 flights a year, has traditionally been the most sought after in the domestic aviation sector, and was also ranked as the third busiest in the world in 2018. But that was till the industry buckled down after the pandemic struck and a lockdown forced airlines to ground their fleet in March.

Though domestic flights resumed on May 25, it is the non-metro routes that have seen the highest traffic, probably because of customers flying back to their hometowns during the lockdown. It also mattered that the Maharashtra government had put a cap on flights that could be operated out of the Mumbai airport.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show